Shaker Investments LLC OH Has $946,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Shaker Investments LLC OH raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 63.5% in the third quarter, HoldingsChannel.com reports. The firm owned 9,575 shares of the exchange traded fund’s stock after purchasing an additional 3,720 shares during the quarter. Shaker Investments LLC OH’s holdings in SPDR S&P Biotech ETF were worth $946,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Carnegie Investment Counsel increased its position in SPDR S&P Biotech ETF by 3.2% during the 3rd quarter. Carnegie Investment Counsel now owns 95,423 shares of the exchange traded fund’s stock valued at $9,428,000 after purchasing an additional 2,975 shares during the period. CWM LLC increased its position in SPDR S&P Biotech ETF by 22.0% during the 3rd quarter. CWM LLC now owns 10,239 shares of the exchange traded fund’s stock valued at $1,012,000 after purchasing an additional 1,849 shares during the period. Daymark Wealth Partners LLC increased its position in SPDR S&P Biotech ETF by 0.9% during the 3rd quarter. Daymark Wealth Partners LLC now owns 17,750 shares of the exchange traded fund’s stock valued at $1,754,000 after purchasing an additional 150 shares during the period. Peddock Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $302,000. Finally, Royal Fund Management LLC grew its position in shares of SPDR S&P Biotech ETF by 388.8% during the 3rd quarter. Royal Fund Management LLC now owns 296,486 shares of the exchange traded fund’s stock worth $29,293,000 after buying an additional 235,835 shares during the period.

SPDR S&P Biotech ETF Stock Up 2.6 %

Shares of XBI stock opened at $98.68 on Friday. The company has a market cap of $7.52 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The firm has a 50 day moving average of $98.54 and a 200-day moving average of $94.17.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.